Key Points
- On December 22, CEO Thomas David Hull III sold 1,000 shares at $39.00 each for $39,000, cutting his stake by 2.65% to 36,719 shares valued at about $1.432 million, according to an SEC filing.
- Hull has made multiple insider sales this year—1,000 shares on Sept. 24, 1,854 on Sept. 29, 1,000 on Oct. 1 and the Dec. 22 sale—totaling 4,854 shares, mostly sold at roughly $43 per share.
- Kewaunee Scientific (KEQU) has a market cap of $109.35M and a P/E of 9.67, reported quarterly EPS of $0.91 (down from $1.01 year-ago), and carries an average analyst rating of Hold.
Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 1,000 shares of the business's stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $39.00, for a total value of $39,000.00. Following the completion of the sale, the chief executive officer owned 36,719 shares of the company's stock, valued at $1,432,041. This trade represents a 2.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Thomas David Hull III also recently made the following trade(s):
- On Wednesday, October 1st, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.09, for a total transaction of $43,090.00.
- On Monday, September 29th, Thomas David Hull III sold 1,854 shares of Kewaunee Scientific stock. The shares were sold at an average price of $43.42, for a total transaction of $80,500.68.
- On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.62, for a total transaction of $43,620.00.
Kewaunee Scientific Stock Performance
Shares of NASDAQ KEQU opened at $38.10 on Wednesday. The stock has a market capitalization of $109.35 million, a P/E ratio of 9.67 and a beta of 0.61. The firm's 50-day moving average price is $40.51 and its two-hundred day moving average price is $47.02. Kewaunee Scientific Corporation has a 52-week low of $30.33 and a 52-week high of $71.33. The company has a quick ratio of 1.71, a current ratio of 2.48 and a debt-to-equity ratio of 0.81.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last released its quarterly earnings results on Wednesday, December 10th. The technology company reported $0.91 EPS for the quarter. The company had revenue of $70.10 million for the quarter. Kewaunee Scientific had a net margin of 4.11% and a return on equity of 22.39%. During the same quarter last year, the firm posted $1.01 earnings per share.
Institutional Trading of Kewaunee Scientific
A number of institutional investors have recently bought and sold shares of the company. Royce & Associates LP acquired a new stake in shares of Kewaunee Scientific in the third quarter worth about $1,663,000. Punch & Associates Investment Management Inc. boosted its position in Kewaunee Scientific by 61.9% during the third quarter. Punch & Associates Investment Management Inc. now owns 70,085 shares of the technology company's stock worth $2,989,000 after purchasing an additional 26,785 shares during the period. Susquehanna International Group LLP bought a new stake in Kewaunee Scientific during the third quarter worth approximately $713,000. American Century Companies Inc. grew its holdings in Kewaunee Scientific by 43.4% during the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company's stock valued at $1,937,000 after purchasing an additional 14,889 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its position in shares of Kewaunee Scientific by 125.7% in the first quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company's stock valued at $764,000 after purchasing an additional 10,803 shares during the period. Institutional investors and hedge funds own 32.69% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have recently commented on the company. Wall Street Zen downgraded Kewaunee Scientific from a "buy" rating to a "hold" rating in a research note on Saturday, December 13th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Kewaunee Scientific in a research note on Wednesday, October 8th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of "Hold".
Read Our Latest Research Report on KEQU
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.
The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
